Oric Pharmaceuticals (ORIC) Operating Income (2019 - 2026)
Oric Pharmaceuticals (ORIC) posted Operating Income of -$39.6 million for Q1 2026, down 14.67% on a QoQ basis from -$34.6 million in Q4 2025, and down 21.09% year-over-year from -$50.2 million in Q1 2025.
Oric Pharmaceuticals (ORIC) Operating Income (2019 - 2026) Analysis & Trends
Oric Pharmaceuticals' Operating Income history runs 8 years deep, the most recent figure standing at -$39.6 million for Q1 2026.
- Quarterly Operating Income fell 21.09% year-over-year to -$39.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$149.9 million (down 2.24% YoY) and the FY2025 annual result came in at -$143.0 million, changed 0.08% from the prior year.
- Operating Income was -$39.6 million for Q1 2026 at Oric Pharmaceuticals, down from -$34.6 million in the prior quarter.
- Across five years, Operating Income topped out at -$20.7 million in Q2 2022 and bottomed at -$39.6 million in Q1 2026.
- A 5-year average of -$31.1 million and a median of -$31.4 million in 2023 frame the typical range for Operating Income.
- Annual changes were most pronounced in 2024 — Operating Income tumbled 44.11% — and 2025, when it rose 12.68%.
- Oric Pharmaceuticals' Operating Income stood at -$22.1 million in 2022, then sank by 42.09% to -$31.4 million in 2023, then decreased by 25.91% to -$39.6 million in 2024, then rose by 12.68% to -$34.6 million in 2025, then declined by 14.67% to -$39.6 million in 2026.
- Business Quant data shows ORIC's Operating Income at -$39.6 million in Q1 2026, -$34.6 million in Q4 2025, and -$36.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.76 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 249.90 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 394.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -445.22 Mn |
| 10 | Oric Pharmaceuticals | 1.29 Bn | 1.01 Bn | - | -39.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -39.62 Mn |
| Dec 31, 2025 | -34.55 Mn |
| Sep 30, 2025 | -36.67 Mn |
| Jun 30, 2025 | -39.06 Mn |
| Mar 31, 2025 | -32.72 Mn |
| Dec 31, 2024 | -39.57 Mn |
| Sep 30, 2024 | -38.32 Mn |
| Jun 30, 2024 | -36.02 Mn |
| Mar 31, 2024 | -28.99 Mn |
| Dec 31, 2023 | -31.43 Mn |
| Sep 30, 2023 | -28.68 Mn |
| Jun 30, 2023 | -24.99 Mn |
| Mar 31, 2023 | -25.68 Mn |
| Dec 31, 2022 | -22.12 Mn |
| Sep 30, 2022 | -25.69 Mn |
| Jun 30, 2022 | -20.70 Mn |
| Mar 31, 2022 | -23.26 Mn |
| Dec 31, 2021 | -22.81 Mn |
| Sep 30, 2021 | -18.46 Mn |
| Jun 30, 2021 | -21.06 Mn |